Terms: = Breast cancer AND MALT1, ENSG00000172175, 10892
19 results:
1. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating malt1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.
Zhou B; Mo Z; Lai G; Chen X; Li R; Wu R; Zhu J; Zheng F
J Exp Clin Cancer Res; 2023 Feb; 42(1):48. PubMed ID: 36797769
[TBL] [Abstract] [Full Text] [Related]
2. Combining precision oncology and immunotherapy by targeting the malt1 protease.
Mempel TR; Krappmann D
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270731
[TBL] [Abstract] [Full Text] [Related]
3. malt1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative breast cancer.
Lee JL; Ekambaram P; Carleton NM; Hu D; Klei LR; Cai Z; Myers MI; Hubel NE; Covic L; Agnihotri S; Krappmann D; Bornancin F; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Mol Cancer Res; 2022 Mar; 20(3):373-386. PubMed ID: 34753803
[TBL] [Abstract] [Full Text] [Related]
4. malt1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
[TBL] [Abstract] [Full Text] [Related]
5. The CARMA3-Bcl10-malt1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive breast cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract] [Full Text] [Related]
6. Bcl10 synergistically links CEACAM3 and TLR-dependent inflammatory signalling.
Sintsova A; Guo CX; Sarantis H; Mak TW; Glogauer M; Gray-Owen SD
Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 28886618
[TBL] [Abstract] [Full Text] [Related]
7. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract] [Full Text] [Related]
8. Deficiency of malt1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
[TBL] [Abstract] [Full Text] [Related]
9. Epithelial growth factor receptor-activated nuclear factor κB signaling and its role in epithelial growth factor receptor-associated tumors.
Pan D; Lin X
Cancer J; 2013; 19(6):461-7. PubMed ID: 24270344
[TBL] [Abstract] [Full Text] [Related]
10. Dissection of signaling in inflammation: three novel inflammatory regulators.
Berger T; Saunders ME; Mak TW
Cold Spring Harb Symp Quant Biol; 2013; 78():141-7. PubMed ID: 25028400
[TBL] [Abstract] [Full Text] [Related]
11. T(14;18)(q32;q21) involving malt1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
[TBL] [Abstract] [Full Text] [Related]
12. breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.
Liguori G; Cantile M; Cerrone M; La Mantia E; Di Bonito M; Zanconati F; Curcio MP; Aquino G; La Mura A; Giannatiempo R; De Chiara A; Lombardi A; Botti G; D'Antonio A; Caraglia M; Franco R
Oncol Rep; 2012 Oct; 28(4):1211-6. PubMed ID: 22842723
[TBL] [Abstract] [Full Text] [Related]
13. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
[TBL] [Abstract] [Full Text] [Related]
14. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
Gyrd-Hansen M; Darding M; Miasari M; Santoro MM; Zender L; Xue W; Tenev T; da Fonseca PC; Zvelebil M; Bujnicki JM; Lowe S; Silke J; Meier P
Nat Cell Biol; 2008 Nov; 10(11):1309-17. PubMed ID: 18931663
[TBL] [Abstract] [Full Text] [Related]
15. malt1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast.
Talwalkar SS; Valbuena JR; Abruzzo LV; Admirand JH; Konoplev SN; Bueso-Ramos CE; Medeiros LJ
Mod Pathol; 2006 Nov; 19(11):1402-8. PubMed ID: 16917511
[TBL] [Abstract] [Full Text] [Related]
16. Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland.
Aro AR; De Koning HJ; Schreck M; Henriksson M; Anttila A; Pukkala E
Psychol Med; 2005 Oct; 35(10):1515-21. PubMed ID: 16164775
[TBL] [Abstract] [Full Text] [Related]
17. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract] [Full Text] [Related]
18. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/malt1 in MALT lymphomas.
Murga Penas EM; Hinz K; Röser K; Copie-Bergman C; Wlodarska I; Marynen P; Hagemeijer A; Gaulard P; Löning T; Hossfeld DK; Dierlamm J
Leukemia; 2003 Nov; 17(11):2225-9. PubMed ID: 12931213
[TBL] [Abstract] [Full Text] [Related]
19. T(14;18)(q32;q21) involving IGH and malt1 is a frequent chromosomal aberration in MALT lymphoma.
Streubel B; Lamprecht A; Dierlamm J; Cerroni L; Stolte M; Ott G; Raderer M; Chott A
Blood; 2003 Mar; 101(6):2335-9. PubMed ID: 12406890
[TBL] [Abstract] [Full Text] [Related]
